Cargando…
Clinical significance of ADAM29 promoting the invasion and growth of gastric cancer cells in vitro
ADAM metallopeptidase domain 29 (ADAM29) belongs to the ADAM family, is a type I integral membrane protein and secrets a glycoprotein that mediates cell-cell and cell-matrix interaction. Aberrant expression of ADAM29 is involved in a number of physiological processes diversification. The purpose of...
Autores principales: | Chen, Hongbing, Wang, Siping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036465/ https://www.ncbi.nlm.nih.gov/pubmed/30008827 http://dx.doi.org/10.3892/ol.2018.8838 |
Ejemplares similares
-
miR-29a suppresses growth and invasion of gastric cancer cells in vitro by targeting VEGF-A
por: Chen, Ling, et al.
Publicado: (2014) -
Clinical significance of TRIM29 expression in patients with gastric cancer
por: Farhadi, Javad, et al.
Publicado: (2022) -
Prognostic Significance of ADAM17 for Gastric Cancer Survival: A Meta-Analysis
por: Ni, Peng, et al.
Publicado: (2020) -
Expression of ADAM29 and FAM135B in the pathological evolution from normal esophageal epithelium to esophageal cancer: Their differences and clinical significance
por: Wang, Tingting, et al.
Publicado: (2020) -
Aberrant expression of ADAM9 in ovarian cancer and its clinical significance
por: Guo, Ting, et al.
Publicado: (2019)